SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice

Sodium-glucose cotransporter (SGLT) 2 inhibitors increase urinary glucose excretion (UGE), leading to blood glucose reductions and weight loss. However, the impacts of SGLT2 inhibition on energy homeostasis and obesity-induced insulin resistance are less well known. Here, we show that empagliflozin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liang, Nagata, Naoto, Nagashimada, Mayumi, Zhuge, Fen, Ni, Yinhua, Chen, Guanliang, Mayoux, Eric, Kaneko, Shuichi, Ota, Tsuguhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478253/
https://www.ncbi.nlm.nih.gov/pubmed/28579299
http://dx.doi.org/10.1016/j.ebiom.2017.05.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478253/
https://www.ncbi.nlm.nih.gov/pubmed/28579299
http://dx.doi.org/10.1016/j.ebiom.2017.05.028

Ejemplares similares